Back to Journals » International Journal of Nanomedicine » Volume 8 » Issue 1

Nanobodies as novel agents for disease diagnosis and therapy

Authors Siontorou CG

Received 24 July 2013

Accepted for publication 23 August 2013

Published 1 November 2013 Volume 2013:8(1) Pages 4215—4227

DOI https://doi.org/10.2147/IJN.S39428

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4


Christina G Siontorou

Department of Industrial Management and Technology, University of Piraeus, Piraeus, Greece

Abstract: The discovery of naturally occurring, heavy-chain only antibodies in Camelidae, and their further development into small recombinant nanobodies, presents attractive alternatives in drug delivery and imaging. Easily expressed in microorganisms and amenable to engineering, nanobody derivatives are soluble, stable, versatile, and have unique refolding capacities, reduced aggregation tendencies, and high-target binding capabilities. This review outlines the current state of the art in nanobodies, focusing on their structural features and properties, production, technology, and the potential for modulating immune functions and for targeting tumors, toxins, and microbes.

Keywords: heavy chain antibodies, nanobodies, antibody expression, molecular display, formatting

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]